Table 4 Characteristics of patients with nocardiosis
From: Clinical characteristics and drug resistance of Nocardia in Henan, China, 2017–2023
Characteristics | Bronchiectasis (n = 39)a | Non bronchiectasis | P value* |
|---|---|---|---|
(n = 29)a | |||
Patient demographics | |||
Male/female | 18/21 | 8/21/2023 | 0.030 |
< 40 years | 8 (20.5%) | 5 (17.2%) | 0.734 |
40–60 years | 13 (33.3%) | 14 (48.3%) | 0.213 |
≥ 60 years | 18 (46.2%) | 10 (34.5%) | 0.333 |
Smoking history | 6 (15.4%) | 11 (37.9%) | 0.034 |
History of Drinking | 3 (7.7%) | 6 (20.7%) | 0.156 |
Underlying diseases | |||
Healthy | 6 (15.4%) | 1 (3.4%) | 0.225 |
COPD | 5 (12.8%) | 3 (10.3%) | 1.000 |
Diabetes | 3 (7.7%) | 9 (31.0%) | 0.013 |
Hypertension | 2 (5.1%) | 6 (20.7%) | 0.065 |
Pulmonary tuberculosis | 6 (15.4%) | 10 (34.5%) | 0.066 |
Coronary heart disease | 0 (0%) | 3 (10.3%) | 0.073 |
Anemia | 2 (5.1%) | 3 (10.3%) | 0.644 |
Chest radiograph | |||
Nodular or consolidative opacities | 38 (97.4%) | 28 (96.5%) | 1.000 |
Cavitary lesion | 6 (15.4%) | 10 (34.5%) | 0.066 |
Pleural effusion | 8 (20.5%) | 13 (44.8%) | 0.032 |
Co-infection | |||
MTB | 4 (10.3%) | 10 (34.5%) | 0.015 |
NTM | 1 (2.6%) | 1 (3.4%) | 1.000 |
Fungus (aspergillosis spp.) | 1 (2.6%) | 4 (13.8%) | 0.155 |
Other bacteria | 11 (28.2%) | 7 (24.1%) | 0.707 |
Outcome | |||
Failer | 1 (2.6%) | 9 (31.0%) | 0.001 |
Cure | 38 (97.4%) | 20 (69.0%) | 0.001 |